682. Deputy Mary Lou McDonald asked the Minister for Health if there are plans to trial the use of a medication (details supplied) in Ireland in view of the fact his drug is currently being tested in the United States of America for use in preserving fertility for endometriosis patients. [70557/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Mary Lou McDonald under the heading Medicinal Products.
8 questions match, newest first.
883. Deputy Mary Lou McDonald asked the Minister for Health if the Government is currently reviewing the reimbursement status of testosterone products prescribed to women. [68963/26]
884. Deputy Mary Lou McDonald asked the Minister for Health the reason female-specific testosterone formulations are not currently included in the free HRT arrangements. [68964/26]
885. Deputy Mary Lou McDonald asked the Minister for Health if she will consider adding appropriate female testosterone formulations to the reimbursement list in the treatment of menopause and perimenopause. [68966/26]
886. Deputy Mary Lou McDonald asked the Minister for Health the steps being taken to ensure that women requiring testosterone are able to access an appropriate formulation without having to pay privately. [68967/26]
1191. Deputy Mary Lou McDonald asked the Minister for Health the position in relation to the approval of the drug ryeqo which is used in other jurisdictions in the treatment of endometriosis; and if she will make a statement on the matter. [35037/26]
3240. Deputy Mary Lou McDonald asked the Minister for Health the specific steps that are being taken to ensure the HSE considers the time-critical nature of the 2026 IPHA Framework Agreement during the current price negotiations for Skyclarys; and the way in which the commitments in the National Rare Disease Strategy 2025-2030 and the 2026 IPHA Framework Agreement, which aims for a 180-day decision timeline, are bein…
778. Deputy Mary Lou McDonald asked the Minister for Health if she intends to review the terms of the drugs payment scheme; if she will extend the long-term illness scheme in order to include rheumatoid arthritis as a long-term chronic illness; and if she will make a statement on the matter. [9782/25]